Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Government Agencies›
Ihealthtech NUS
AddedFeb 16, 2024
UpdatedJun 28, 2026
Ihealthtech NUS

Ihealthtech NUS

Operating

NUS Institute for Health Innovation & Technology: Pioneering solutions for healthcare challenges.

Founded
2017
Location
Singapore, Singapore, SG
Overview
Compare
Employees
Website

The NUS Institute for Health Innovation & Technology (iHealthtech) was established to develop pioneering solutions for healthcare challenges. Its core mission is to advance health through innovation, focusing on creating cutting-edge medical technologies and methodologies. iHealthtech offers a range of services including research and development in medical sciences, and the creation of robust wearable health devices. The institute primarily targets the healthcare market, aiming to improve patient outcomes and streamline medical processes.

Notable figures associated with iHealthtech include Professor Lim Chwee Teck, who has been elected as a Fellow of the Royal Society. The institute has achieved significant milestones such as the launch of the CN Lee Professorship in Medical Sciences and the development of new materials for wearable technology. Through its innovative contributions, iHealthtech has made a substantial impact on the healthcare industry, driving forward advancements that address critical medical needs.

Ihealthtech NUS - Similar Organizations

Sbri Healthcare logo

Sbri Healthcare

Innovative Health Initiative logo

Innovative Health Initiative

ihi.europa.eu

Arpa-H logo

Arpa-H

arpa-h.gov

Cihr logo

Cihr

cihr-irsc.gc.ca

Johns Hopkins University School of Medicine logo

Johns Hopkins University School of Medicine

University of North Texas Health Science Center logo

University of North Texas Health Science Center

unthsc.edu

Massachusetts eHealth Institute logo

Massachusetts eHealth Institute

mehi.masstech.org

Andhealth logo

Andhealth

andhealth.com.au

Ihealthtech NUS - Quick Facts

What organizations are similar to Ihealthtech NUS?

Organizations similar to Ihealthtech NUS include Sbri Healthcare, Innovative Health Initiative, Arpa-H and Cihr.

When was Ihealthtech NUS founded?

Ihealthtech NUS was founded in 2017.

Where is Ihealthtech NUS' headquarters located?

Ihealthtech NUS' headquarters is located in Singapore, Singapore, SG.

How many employees does Ihealthtech NUS have?

Ihealthtech NUS has 50 employees as of Feb 4, 2024.

Ihealthtech NUS - Classification

Ownership
  • Government
Technology
  • Medical Technology
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Healthcare Solutions
Tags
  • Consulting
  • Healthtech
  • Research
NAICS
  • 610000Educational Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools